Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 7% | |
| epithelial cell | 4 studies | 33% ± 11% | |
| astrocyte | 4 studies | 24% ± 6% | |
| lymphocyte | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 37% ± 6% | |
| glutamatergic neuron | 3 studies | 42% ± 7% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 6% | |
| macrophage | 3 studies | 20% ± 3% | |
| transit amplifying cell | 3 studies | 25% ± 14% | |
| oligodendrocyte | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1803.42 | 1445 / 1445 | 100% | 10.89 | 183 / 183 |
| lung | 100% | 1962.78 | 578 / 578 | 100% | 10.32 | 1155 / 1155 |
| ovary | 100% | 2398.19 | 180 / 180 | 100% | 8.51 | 430 / 430 |
| stomach | 100% | 1520.52 | 359 / 359 | 100% | 8.51 | 286 / 286 |
| bladder | 100% | 1777.86 | 21 / 21 | 100% | 9.62 | 503 / 504 |
| breast | 100% | 2114.73 | 459 / 459 | 100% | 12.12 | 1115 / 1118 |
| prostate | 100% | 2058.53 | 245 / 245 | 100% | 8.73 | 500 / 502 |
| thymus | 100% | 2517.14 | 653 / 653 | 100% | 12.67 | 602 / 605 |
| intestine | 100% | 1966.33 | 966 / 966 | 99% | 8.77 | 524 / 527 |
| kidney | 100% | 1478.26 | 89 / 89 | 99% | 10.46 | 895 / 901 |
| uterus | 100% | 2435.98 | 170 / 170 | 99% | 12.02 | 454 / 459 |
| pancreas | 100% | 1192.33 | 328 / 328 | 99% | 9.01 | 176 / 178 |
| brain | 99% | 1182.83 | 2604 / 2642 | 100% | 8.02 | 705 / 705 |
| adrenal gland | 100% | 1714.20 | 258 / 258 | 98% | 6.46 | 226 / 230 |
| skin | 100% | 2202.13 | 1809 / 1809 | 97% | 8.21 | 458 / 472 |
| liver | 100% | 1345.85 | 226 / 226 | 95% | 6.08 | 384 / 406 |
| adipose | 100% | 1996.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1632.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.51 | 29 / 29 |
| muscle | 100% | 1642.93 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2609.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.98 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.51 | 1 / 1 |
| heart | 99% | 942.82 | 856 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 5.43 | 74 / 80 |
| peripheral blood | 89% | 1288.67 | 830 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0031124 | Biological process | mRNA 3'-end processing |
| GO_0016076 | Biological process | snRNA catabolic process |
| GO_0006396 | Biological process | RNA processing |
| GO_0031499 | Cellular component | TRAMP complex |
| GO_0005730 | Cellular component | nucleolus |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | ZCCHC8 |
| Protein name | Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8) Zinc finger CCHC-type containing 8 |
| Synonyms | |
| Description | FUNCTION: Scaffolding subunit of the trimeric nuclear exosome targeting (NEXT) complex that is involved in the surveillance and turnover of aberrant transcripts and non-coding RNAs . NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. May be involved in pre-mRNA splicing (Probable). It is required for 3'-end maturation of telomerase RNA component (TERC), TERC 3'-end targeting to the nuclear RNA exosome, and for telomerase function . . |
| Accessions | F5H6J5 ENST00000536306.5 [Q6NZY4-2] ENST00000633063.3 [Q6NZY4-1] F5GYI9 ENST00000540586.1 F5GX80 ENST00000544054.5 ENST00000536663.5 ENST00000543897.5 [Q6NZY4-2] Q6NZY4 |